Advisory Services Network, LLC Kamada LTD Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$5.25 - $5.87 $8,310 - $9,292	-1,583 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.67 - $6.33 $8,975 - $10,020	1,583 New	1,583 $9,000
Q1 2021 May 24, 2021	SELL	$6.02 - $8.06 $9,529 - $12,758	-1,583 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.02 - $11.73 $12,695 - $18,568	1,583 New	1,583 $13,000
Q2 2020 Aug 10, 2020	SELL	$5.37 - $9.45 $8,500 - $14,959	-1,583 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$4.97 - $7.7 $7,867 - $12,189	1,583 New	1,583 $11,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $260M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.